Background:
Hypertension, particularly resistant hypertension, persists as a major global burden associated with significant challenges in therapeutic management. Baxdrostat, a selective aldosterone synthase inhibitor, can be investigated as a potential therapy for blood pressure treatment. We conducted a meta-analy...
Hamza Sajid, K. M. Hassan, Hamdia Gul Aslam et al.· Circulation· 0 citations
Background:
Ischemic cardiomyopathy (ICM) is a major cause of cardiovascular morbidity and mortality. Although advances in cardiovascular prevention and management have improved outcomes, whether these improvements have occurred equitably across demographic groups remains poorly characterized. We evaluated national...
Hassan E. Muhammad, Hamza Sajid, C. Sohail et al.· Circulation· 0 citations
Background:
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease despite advances in targeted therapies. Sotatercept, a first-in-class activin receptor type IIA ligand trap, targets pulmonary vascular remodeling and may provide a disease-modifying treatment approach.
Research ques...
Ivy Lai Jialin, Bilal Younas, Muhammad Hassan et al.· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.